Dasatinib reverses drug resistance by downregulating MDR1 and Survivin in Burkitt lymphoma cells
Abstract Background Current chemotherapies for Burkitt lymphoma (BL) have dramatically improved its clinical outcome. However, chemoresistance can lead to chemotherapy failure and very poor prognosis; thus, novel strategies are urgently required for patients with drug-resistant BL. To investigate th...
Enregistré dans:
Auteurs principaux: | , , , , , , , , |
---|---|
Format: | Livre |
Publié: |
BMC,
2020-03-01T00:00:00Z.
|
Sujets: | |
Accès en ligne: | Connect to this object online. |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Internet
Connect to this object online.3rd Floor Main Library
Cote: |
A1234.567 |
---|---|
Exemplaire 1 | Disponible |